I would like to analyse metaproteomics data from healthy and IBD patients. Does the proteomics data available at IBDMDB consists only IBD patients or also healthy subjects? And do you have more information about the IBD cohorts (e.g. population size, age, gender, …) that are part of the proteomics data?
I am happy to hear from you.